Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Library: SystematicReviewExcludedStudies: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer

Official URL: https://fevir.net/resources/Library/179632 Version: 1.0.0-ballot3
Standards status: Informative Computable Name:
Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#179632, OID:2.16.840.1.113883.4.642.40.44.28.2

Usage: Evidence Communication: SystematicReviewExcludedStudies

Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/

11 excluded studies

Metadata
Title SystematicReviewExcludedStudies: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer
Version 1.0.0-ballot3
Identifier 179632
Identifier urn:oid:2.16.840.1.113883.4.642.40.44.28.2
Subject Type SystematicReviewEligibilityCriteria: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer
Use Context Evidence Communication = SystematicReviewExcludedStudies
Jurisdiction World
Steward (Publisher) HL7 International / Clinical Decision Support
Steward Contact HL7 International / Clinical Decision Support
Developer Brian S. Alper
Description

11 excluded studies
Copyright

https://creativecommons.org/licenses/by-nc-sa/4.0/
Type Asset Collection
Parameters
Parameter None
Generated using version 0.5.4 of the sample-content-ig Liquid templates